UNITED STATES
                     SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                  FORM 12b-25

NOTIFICATION OF LATE FILING                  SEC FILE NUMBER: 000-21725
                                                             -----------

                                             CUSIP NUMBER:  827 087 20 6
                                                           --------------

[X]Form 10-K [ ]Form 20-F  [ ] Form 11-K  [ ] Form 10-Q [ ]Form N-SAR

For Period Ended:  May 31, 2001
                 -----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:

	Read Attached Instruction Sheet Before Preparing Form.  Please
Print or Type.  Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.

	If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:


PART I - REGISTRANT INFORMATION
         ----------------------

        Full Name of Registrant

	Silk Botanicals.com, Inc.
- ---------------------------------------------------------------------------
	Former Name if Applicable

	N/A
- ---------------------------------------------------------------------------

Address of Principal Office (Street and Number)

	975 S. Congress Avenue, Suite 102
- ---------------------------------------------------------------------------

City, State and Zip Code

     Delray Beach, Florida 33445
- ---------------------------------------------------------------------------


PART II - RULES 12b-25(b) AND (c)
          -----------------------

If the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed.  (Check box if appropriate)


    1


[ ] (a)	The reasons described in reasonable detail in Part III of
        this form could not be eliminated without unreasonable
        effort or expense.
[X] (b)	The subject annual report, semi-annual report, transition
        report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
        portion thereof, will be filed on or before the fifteenth
        calendar day following the prescribed due date; or the
        subject quarterly report or transition report on Form 10-Q,
        or portion thereof will be filed on or before the fifth
        calendar day following the prescribed due date; and
[ ] (c)	The accountant's statement or other exhibit required by
        Rule 12b-25(c) has been attached if applicable.


PART III - NARRATIVE
           ---------

State below in reasonable detail the reasons why Forms 10-K, 20-F, 10-
Q, N-SAR, or the transition report or portion thereof, could not be
filed within the prescribed time period.

	Management and the Company's Auditor are in the process of
        completing the Company's Form 10-KSB for the fiscal year ended
        May 31, 2001.  It is anticipated that the review of the
        Form 10KSB will be completed in time for filing of the
        Form 10-KSB for the period ended May 31, 2001 within the
        time allowed by this extension.


PART IV - OTHER INFORMATION
          -----------------

(1)	Name and telephone number of person to contact in regard to this
notification.

	Joseph Bergmann               (561)        265-3600
        ---------------            ----------- ------------------
          (Name)                   (Area Code) (Telephone Number)

(2)	Have all other period reports required under Section 13 or 15(d)
of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such short period that the registrant was required to file
such report(s) been filed?  If answer is no, identify report(s).

                       [X] Yes         [ ] No

(3)	Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected in the earnings statement to be included in the
subject report or portion thereof?

                       [ ] Yes         [X] No


    2


	If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.

	The Registrant, Silk Botanicals.com, Inc., has caused this
notification to be signed on its behalf by the undersigned hereunto
duly authorized.



                                             By:__/s/Joseph Bergmann________
Date: August 28, 2001                           Joseph Bergmann, President


    3